Shopping Cart
- Remove All
- Your shopping cart is currently empty
ARN22089, an orally active novel class of trisubstituted pyrimidine, inhibits the interaction of CDC42 GTPases with specific downstream effectors and blocks tumor growth in a BRAF mutant mouse melanoma model [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $123 | In Stock | |
5 mg | $296 | In Stock | |
10 mg | $449 | In Stock | |
25 mg | $757 | In Stock | |
50 mg | $1,130 | In Stock | |
100 mg | $1,690 | In Stock | |
200 mg | $2,290 | In Stock | |
1 mL x 10 mM (in DMSO) | $333 | In Stock |
Description | ARN22089, an orally active novel class of trisubstituted pyrimidine, inhibits the interaction of CDC42 GTPases with specific downstream effectors and blocks tumor growth in a BRAF mutant mouse melanoma model [1]. |
Molecular Weight | 373.49 |
Formula | C23H27N5 |
Cas No. | 2248691-29-2 |
Smiles | N(C1=CC(=NC(=N1)C2CCNCC2)C3=CC=CC=C3)C4=CC(N(C)C)=CC=C4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.